A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors.
Lanning, Bryan R
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. [electronic resource] - Nature chemical biology Sep 2014 - 760-767 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1552-4469
10.1038/nchembio.1582 doi
Adenine--analogs & derivatives
Agammaglobulinaemia Tyrosine Kinase
Cell Line, Tumor
Cell Survival--drug effects
Cysteine--chemistry
Genes, erbB-1--genetics
Humans
Kinetics
Piperidines
Protein Kinase Inhibitors--pharmacology
Protein Kinases--metabolism
Protein-Tyrosine Kinases--antagonists & inhibitors
Proteome--genetics
Pyrazoles--pharmacology
Pyrimidines--pharmacology
Signal Transduction--drug effects
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. [electronic resource] - Nature chemical biology Sep 2014 - 760-767 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1552-4469
10.1038/nchembio.1582 doi
Adenine--analogs & derivatives
Agammaglobulinaemia Tyrosine Kinase
Cell Line, Tumor
Cell Survival--drug effects
Cysteine--chemistry
Genes, erbB-1--genetics
Humans
Kinetics
Piperidines
Protein Kinase Inhibitors--pharmacology
Protein Kinases--metabolism
Protein-Tyrosine Kinases--antagonists & inhibitors
Proteome--genetics
Pyrazoles--pharmacology
Pyrimidines--pharmacology
Signal Transduction--drug effects